doi: 10.1016/j.reprotox.2006.03.003
2026 Jan;32(1):353-361
3.1.1 Liraglutide: weight, ectopic fat, and reproductive endocrine outcomes In placebo-controlled trials with approximately 26 weeks of follow-up, liraglutide 1.8 mg/d demonstrated stable, clinically meaningful weight loss, accompanied by improvements in several reproductive endocrine markers
It's never something where someone says, Oh, I don't want, you know, I wouldn't want to be on insulin or they shouldn't be on insulin
Hypoglycemia: When used with other diabetes medications, there is a risk of low blood sugar levels
I always recommend trying natural solutions before trying laxatives, as they can be harsh and have GI side effects of their own